Amanita Gummies Exploit Regulatory Gaps

Vendors are packaging Amanita muscaria (a non‑psilocybin intoxicant) as 'magic mushroom' gummies and selling them through smoke shops and novelty channels, often without accurate labeling, dosage guidance or safety testing. Because its active compounds act differently from psilocybin and regulatory categories are ambiguous, these products create a blind spot for drug policy, age‑verification and public‑health surveillance. — This phenomenon forces regulators, retailers and public‑health officials to decide whether to treat alternative psychedelic products as controlled drugs, consumer goods, or something new — with consequences for youth exposure, poisoning surveillance, and advertising rules.